| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07383441 Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer |
Recruitment opened |
| 2026-06-12 | NCT07383441 Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer |
Trial sites expanded: 0 -> 41 locations |
| 2026-06-10 | NCT07037004 Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal… |
Recruitment opened |
| 2026-05-29 | NCT07189390 The Bloom Infant Probiotic (BIP) Study |
Recruitment opened |
| 2026-05-29 | NCT07189390 The Bloom Infant Probiotic (BIP) Study |
date change Primary completion pushed: 2029-04 -> 2029-05 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07383441 | Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer | Advanced Clear Cell Renal Cell Carcinoma | Recruiting |
| Phase 2 | |||
| NCT07293910 | Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for… | HELICOBACTER PYLORI INFECTIONS | Recruiting |
| NCT07189390 | The Bloom Infant Probiotic (BIP) Study | Infant, Newborn | Recruiting |
| NCT07037004 | Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal… | Clear Cell Renal Cell Carcinoma | Recruiting |
| NCT07474064 | Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving… | Muscle Invasive Bladder Cancer (MIBC) | Not Yet Recruiting |
| NCT06949800 | CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial | HSIL, High Grade Squamous Intraepithelial Lesion | Not Yet Recruiting |
| NCT07413744 | The Gut - PRO Study | Alzheimer Disease | Not Yet Recruiting |
| Phase 1 | |||
| NCT07234227 | Genitourinary Study of Fostering Lactobacillus to Optimize the Microbiome in Women's… | Recurrent UTIs | Not Yet Recruiting |
| NCT05122546 | CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or… | Advanced Clear Cell Renal Cell Carcinoma | Active, Not Recruiting |
| NCT03922035 | CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic… | Hematopoietic and Lymphoid Cell Neoplasm | Active, Not Recruiting |
| Not specified | |||
| NCT07331987 | Efficacy and Safety of Probiotics for Anxiety Depression | Anxiety Depression | Not Yet Recruiting |